Solid Biosciences (SLDB) Return on Sales: 2023-2024
Historic Return on Sales for Solid Biosciences (SLDB) over the last 1 years, with Dec 2024 value amounting to 354.70%.
- Solid Biosciences' Return on Sales rose 13350.00% to 354.70% in Q4 2024 from the same period last year, while for Dec 2024 it was 354.70%, marking a year-over-year increase of 13350.00%. This contributed to the annual value of 354.70% for FY2024, which is 13400.00% up from last year.
- Latest data reveals that Solid Biosciences reported Return on Sales of 354.70% as of Q4 2024, which was up 25.85% from 281.86% recorded in Q3 2024.
- Solid Biosciences' Return on Sales' 5-year high stood at 354.70% during Q4 2024, with a 5-year trough of -69.02% in Q3 2023.
- Over the past 2 years, Solid Biosciences' median Return on Sales value was 227.89% (recorded in 2023), while the average stood at 207.30%.
- Data for Solid Biosciences' Return on Sales shows a peak YoY spiked of 35,088bps (in 2024) over the last 5 years.
- Solid Biosciences' Return on Sales (Quarterly) stood at 221.21% in 2023, then surged by 13,350bps to 354.70% in 2024.
- Its Return on Sales was 354.70% in Q4 2024, compared to 281.86% in Q3 2024 and 234.57% in Q2 2024.